Uso de parámetros hematológicos para tratamiento antirretroviral en un grupo de pacientes VIH/sida
Resumen
Palabras clave
Referencias
Michael S. Gottlieb. Pneumocystis pneumonia- Los Angeles. Am J Public Health [Internet]. 2006 June [citado 16 May 2011];96(6). Disponible en:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1470612/
Friedman-Kien A, Laubenstein L, Marmor M, Hymes K, Green J. Kaposi’s sarcoma and pneumocystis pneumonia among homosexual men - New York City and California. Morb Mortal Wkly Rep [Internet]. 1981 Jul [cited 2011 Jun 16];30. Disponible en:
http://www.cdc.gov/hiv/resources/reports/mmwr/pdf/mmwr04jul81.pdf
Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA [et al] Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med [Internet]. 1981 Dec [cited 2011 Jun 16];305(24). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/6272109
Boyle BA. HIV in developing countries: a tragedy only starting to unfold. The AIDS Reader [Internet]. 2000 [cited 2011 Jun 16];10(2). Disponible en:
http://www.medscape.com/viewarticle/410262
UNAIDS/WHO. AIDS epidemic update: december 2007. Joint United Nations Programme on HIV/AIDS [cited 2011 Jun 16]. Disponible en:
http://data.unaids.org/pub/epislides/2007/2007_epiupdate_en.pdf
The global HIV/AIDS epidemic 2002-2003 [monografía en CD-ROM]. Geneva: Joint United Nations Programmer on HIV/AIDS; 2002.
Saidel T, Vu HT, Sartchenko I. Growing in silence: selected regions and countries with expanding HIV/AIDS epidemics. AIDS [Internet]. 2003 [cited 2011 Jun 16];17(Suppl 4). Disponible en:
http://www.ncbi.nlm.nih.gov/pubmed/15080179
Suardíaz J, Cruz C, Colina A, Alerm A, Alfonso ME, Alfonso Y. Laboratorio Clínico [Internet]. La Habana; 2004 [citado el 24 Jul 2007]. Disponible en:
http://es.scribd.com/doc/29337818/Laboratorio-Clinico
WHO, HIV/AIDS, Department Family and Community Health Cluster. Scalling up antiretroviral therapy in resource-limited setting: guide for a public health approach. Ginebra. OMS [Internet]. 2002 Jun [cited 2011 Jun
. Disponible en: http://data.unaids.org/publications/IRC-pub01/jc354-scalingupguidelinesdoc_en.pdf
Mekonen Y, Dukers NH, Sander E, Wendeliena D, Dawita W, Schaap A [et al]. Simple markers for initiating antiretroviral therapy among HIV-infected
Ethiopians. AIDS [Internet]. 2003 [cited 2011 Jun 16];17(6). Disponible en:
http://journals.lww.com/aidsonline/Abstract/2003/04110/Simple_markers_for _initiating_antiretroviral.6.aspx
Rodriguez WR, Christodoulides N, Floriano PN, Graham S, Mohanty S, Dixon M [et al]. A microchip CD4 counting method for HIV monitoring in resource-poor settings. Plos Medicine [Internet]. 2005 Jul [cited 2011 Jun
. Disponible en:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020182
Liotta G, Perno CF, Ceffa S, Gialloreti LE, Coehlo E, Fulvio E [et al]. Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource-limited settings? AIDS [Internet]. 2004 Apr [cited 2007 Jul 27];18(7). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15096818
Van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H, van der Westhuizen M [et al]. Correlation among total lymphocyte count, absolute CD4+ count and CD4+ percentage in a group of HIV-1-infected South
African patients. J Acquir Immune Defic Syndr Hum Retrovirol [Internet]. 1998 Nov [cited 2011 Jun 16];19(3). Disponible en:
http://journals.lww.com/jaids/fulltext/1998/11010/correlation_among_total_ly mphocyte_count,_absolute.5.aspx
Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings. AIDS. [Internet]. 2003 Mar [cited 2011 Jun 16];17(4). Disponible en:
http://www.ncbi.nlm.nih.gov/pubmed/12598774
Akinola NO, Olasode O, Adedirau IA, Onayemi O, Murainah A, Irinoye O [et al]. The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV infected individual in a resource- limited setting. Clin Infect Dis [Internet].
[cited 2011 Jun 16];39. Disponible en:
http://cid.oxfordjournals.org/content/39/4/579.full.pdf
Spacek LA, Griswold M, Quinn TC, Moore RD. Total lymphocyte count is a useful tool for the timing of opportunistic infection prophylaxis in India and
other resource-constrained countries. J Acquir Immune Defic Synd [Internet]. 2003 Jun [cited 2011 Jun 16];31(4). Disponible en:
http://journals.lww.com/aidsonline/Fulltext/2003/06130/Increasing_rates_of_malarial_fever_with.5.aspx
Angelo AL, Angelo CD, Torres AJ, Costa Ramos AM, Lima M, Martins NE [et al]. Evaluating total lymphocyte counts as a substitute for CD4 counts in
the follow up of AIDS patients. Braz J Infect Dis [Internet]. 2007 Oct [cited 2011 Jun 16];11(5). Disponible en:
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413867020070005
García VE, Gárgolas M y Fernandez Guerrero ML. Relación entre velocidad de sedimentación globular, situación clínica e inmunitaria, y carga
viral en pacientes infectados por el VIH no hospitalizados. Rev Esp de Quimioterapia [Internet]. 2001 Sept [citado 27 Jul 2007];14(3). Disponible en: http://www.seq.es/seq/html/revista_seq/0301/or2.html
Piedras RJ, Barrales BO, Reyes LAR, López Karpovitch X. Diferencia en la interpretación diagnóstica de la velocidad de sedimentación globular entre los métodos de Wintrobe y Westergren automatizado. Lab Acta [Internet].
[citado 27 Jul 2007];15(1). Disponible en:
http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_revista=3&id_seccion=13&id_ejemplar=1359&id_articulo=13250
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2020 Reinaldo Luis Menéndez Capote, Maria de los Ángeles Chappotten Delahant, Thelma Tápanes Fernández, Juan Franscico Banderas Tirado
![Licencia de Creative Commons](https://i.creativecommons.org/l/by-nc/4.0/88x31.png)
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.